Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients
The long-term consequences of the coronavirus disease 19 (COVID-19) are likely to be frequent but results hitherto are inconclusive. Therefore, we aimed to define the incidence of long-term COVID signs and symptoms as defined by the World Health Organization, using a systematic review and meta-analy...
Gespeichert in:
| Veröffentlicht in: | Internal and emergency medicine 2023-08, Vol.18 (5), p.1573-1581 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1581 |
|---|---|
| container_issue | 5 |
| container_start_page | 1573 |
| container_title | Internal and emergency medicine |
| container_volume | 18 |
| creator | Di Gennaro, Francesco Belati, Alessandra Tulone, Ottavia Diella, Lucia Fiore Bavaro, Davide Bonica, Roberta Genna, Vincenzo Smith, Lee Trott, Mike Bruyere, Olivier Mirarchi, Luigi Cusumano, Claudia Dominguez, Ligia Juliana Saracino, Annalisa Veronese, Nicola Barbagallo, Mario |
| description | The long-term consequences of the coronavirus disease 19 (COVID-19) are likely to be frequent but results hitherto are inconclusive. Therefore, we aimed to define the incidence of long-term COVID signs and symptoms as defined by the World Health Organization, using a systematic review and meta-analysis of observational studies. A systematic search in several databases was carried out up to 12 January 2022 for observational studies reporting the cumulative incidence of long COVID signs and symptoms divided according to body systems affected. Data are reported as incidence and 95% confidence intervals (CIs). Several sensitivity and meta-regression analyses were performed. Among 11,162 papers initially screened, 196 were included, consisting of 120,970 participants (mean age: 52.3 years; 48.8% females) who were followed-up for a median of six months. The incidence of any long COVID symptomatology was 56.9% (95% CI 52.2–61.6). General long COVID signs and symptoms were the most frequent (incidence of 31%) and digestive issues the least frequent (7.7%). The presence of any neurological, general and cardiovascular long COVID symptomatology was most frequent in females. Higher mean age was associated with higher incidence of psychiatric, respiratory, general, digestive and skin conditions. The incidence of long COVID symptomatology was different according to continent and follow-up length. Long COVID is a common condition in patients who have been infected with SARS-CoV-2, regardless of the severity of the acute illness, indicating the need for more cohort studies on this topic. |
| doi_str_mv | 10.1007/s11739-022-03164-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9709360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2848016155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-a8f772721b8a3612922f5787838cff50aefa15173fa297fb4d2281bc900677003</originalsourceid><addsrcrecordid>eNp9Ustu1DAUjRCIPuAHWCBLbFhg8COxHRZI1fAaqVIlCmwtx3OdukrsNE5mNMv-OZ6Z0gILVr6Sz-Peo1MULyh5SwmR7xKlkteYMIYJp6LEm0fFMa0lwTUX4nGeFVOYlKU8Kk5SuiakqgSVT4sjLsqyZoIcF7fLYP0KggUUHepiaNHi4ufyI6Y18gENEIcO0MZPV2gYYe3jnNDl2bdLvIhrlhEO7ORjeI8MSts0QW8mb9EOCRtkwgr1MBlsgum2yaedB2XkTd4RDRkJYUrPiifOdAme372nxY_Pn74vvuLziy_Lxdk5thVVEzbKSckko40yXFBWM-YqqaTiyjpXEQPO0CoH4gyrpWvKFWOKNrYmREhJCD8tPhx0h7npYWWz92g6PYy-N-NWR-P13z_BX-k2rnVeNue5E-AHgc5DCzqOjddrtifu57lrtbG6Ac2YUJqTWnKRWa_vbMd4M0OadO-Tha4zAXKYmsmSV6TivM7QV_9Ar-M85ugySpWKUEGrKqPYAWXHmNII7v4ESvSuF_rQC517ofe90JtMevnn8feU30V4OC7lr9DC-OD9H9lfOcrB3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2848016155</pqid></control><display><type>article</type><title>Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Di Gennaro, Francesco ; Belati, Alessandra ; Tulone, Ottavia ; Diella, Lucia ; Fiore Bavaro, Davide ; Bonica, Roberta ; Genna, Vincenzo ; Smith, Lee ; Trott, Mike ; Bruyere, Olivier ; Mirarchi, Luigi ; Cusumano, Claudia ; Dominguez, Ligia Juliana ; Saracino, Annalisa ; Veronese, Nicola ; Barbagallo, Mario</creator><creatorcontrib>Di Gennaro, Francesco ; Belati, Alessandra ; Tulone, Ottavia ; Diella, Lucia ; Fiore Bavaro, Davide ; Bonica, Roberta ; Genna, Vincenzo ; Smith, Lee ; Trott, Mike ; Bruyere, Olivier ; Mirarchi, Luigi ; Cusumano, Claudia ; Dominguez, Ligia Juliana ; Saracino, Annalisa ; Veronese, Nicola ; Barbagallo, Mario</creatorcontrib><description>The long-term consequences of the coronavirus disease 19 (COVID-19) are likely to be frequent but results hitherto are inconclusive. Therefore, we aimed to define the incidence of long-term COVID signs and symptoms as defined by the World Health Organization, using a systematic review and meta-analysis of observational studies. A systematic search in several databases was carried out up to 12 January 2022 for observational studies reporting the cumulative incidence of long COVID signs and symptoms divided according to body systems affected. Data are reported as incidence and 95% confidence intervals (CIs). Several sensitivity and meta-regression analyses were performed. Among 11,162 papers initially screened, 196 were included, consisting of 120,970 participants (mean age: 52.3 years; 48.8% females) who were followed-up for a median of six months. The incidence of any long COVID symptomatology was 56.9% (95% CI 52.2–61.6). General long COVID signs and symptoms were the most frequent (incidence of 31%) and digestive issues the least frequent (7.7%). The presence of any neurological, general and cardiovascular long COVID symptomatology was most frequent in females. Higher mean age was associated with higher incidence of psychiatric, respiratory, general, digestive and skin conditions. The incidence of long COVID symptomatology was different according to continent and follow-up length. Long COVID is a common condition in patients who have been infected with SARS-CoV-2, regardless of the severity of the acute illness, indicating the need for more cohort studies on this topic.</description><identifier>ISSN: 1828-0447</identifier><identifier>EISSN: 1970-9366</identifier><identifier>DOI: 10.1007/s11739-022-03164-w</identifier><identifier>PMID: 36449260</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Ce-Systematic Reviews and Meta-analysis ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - epidemiology ; COVID-19 : diagnosis ; Emergency Medicine ; Female ; Human health sciences ; Humans ; Incidence ; Internal Medicine ; Long COVID ; Male ; management and prognosis ; Medicine ; Medicine & Public Health ; Meta-analysis ; Middle Aged ; Observational studies ; Post-Acute COVID-19 Syndrome ; Public health, health care sciences & services ; RNA, Viral ; Santé publique, services médicaux & soins de santé ; SARS-CoV-2 ; Sciences de la santé humaine ; Severe acute respiratory syndrome coronavirus 2 ; Systematic review</subject><ispartof>Internal and emergency medicine, 2023-08, Vol.18 (5), p.1573-1581</ispartof><rights>The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI) 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).</rights><rights>The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI) 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-a8f772721b8a3612922f5787838cff50aefa15173fa297fb4d2281bc900677003</citedby><cites>FETCH-LOGICAL-c518t-a8f772721b8a3612922f5787838cff50aefa15173fa297fb4d2281bc900677003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11739-022-03164-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11739-022-03164-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36449260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Di Gennaro, Francesco</creatorcontrib><creatorcontrib>Belati, Alessandra</creatorcontrib><creatorcontrib>Tulone, Ottavia</creatorcontrib><creatorcontrib>Diella, Lucia</creatorcontrib><creatorcontrib>Fiore Bavaro, Davide</creatorcontrib><creatorcontrib>Bonica, Roberta</creatorcontrib><creatorcontrib>Genna, Vincenzo</creatorcontrib><creatorcontrib>Smith, Lee</creatorcontrib><creatorcontrib>Trott, Mike</creatorcontrib><creatorcontrib>Bruyere, Olivier</creatorcontrib><creatorcontrib>Mirarchi, Luigi</creatorcontrib><creatorcontrib>Cusumano, Claudia</creatorcontrib><creatorcontrib>Dominguez, Ligia Juliana</creatorcontrib><creatorcontrib>Saracino, Annalisa</creatorcontrib><creatorcontrib>Veronese, Nicola</creatorcontrib><creatorcontrib>Barbagallo, Mario</creatorcontrib><title>Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients</title><title>Internal and emergency medicine</title><addtitle>Intern Emerg Med</addtitle><addtitle>Intern Emerg Med</addtitle><description>The long-term consequences of the coronavirus disease 19 (COVID-19) are likely to be frequent but results hitherto are inconclusive. Therefore, we aimed to define the incidence of long-term COVID signs and symptoms as defined by the World Health Organization, using a systematic review and meta-analysis of observational studies. A systematic search in several databases was carried out up to 12 January 2022 for observational studies reporting the cumulative incidence of long COVID signs and symptoms divided according to body systems affected. Data are reported as incidence and 95% confidence intervals (CIs). Several sensitivity and meta-regression analyses were performed. Among 11,162 papers initially screened, 196 were included, consisting of 120,970 participants (mean age: 52.3 years; 48.8% females) who were followed-up for a median of six months. The incidence of any long COVID symptomatology was 56.9% (95% CI 52.2–61.6). General long COVID signs and symptoms were the most frequent (incidence of 31%) and digestive issues the least frequent (7.7%). The presence of any neurological, general and cardiovascular long COVID symptomatology was most frequent in females. Higher mean age was associated with higher incidence of psychiatric, respiratory, general, digestive and skin conditions. The incidence of long COVID symptomatology was different according to continent and follow-up length. Long COVID is a common condition in patients who have been infected with SARS-CoV-2, regardless of the severity of the acute illness, indicating the need for more cohort studies on this topic.</description><subject>Ce-Systematic Reviews and Meta-analysis</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 : diagnosis</subject><subject>Emergency Medicine</subject><subject>Female</subject><subject>Human health sciences</subject><subject>Humans</subject><subject>Incidence</subject><subject>Internal Medicine</subject><subject>Long COVID</subject><subject>Male</subject><subject>management and prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Observational studies</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>Public health, health care sciences & services</subject><subject>RNA, Viral</subject><subject>Santé publique, services médicaux & soins de santé</subject><subject>SARS-CoV-2</subject><subject>Sciences de la santé humaine</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Systematic review</subject><issn>1828-0447</issn><issn>1970-9366</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9Ustu1DAUjRCIPuAHWCBLbFhg8COxHRZI1fAaqVIlCmwtx3OdukrsNE5mNMv-OZ6Z0gILVr6Sz-Peo1MULyh5SwmR7xKlkteYMIYJp6LEm0fFMa0lwTUX4nGeFVOYlKU8Kk5SuiakqgSVT4sjLsqyZoIcF7fLYP0KggUUHepiaNHi4ufyI6Y18gENEIcO0MZPV2gYYe3jnNDl2bdLvIhrlhEO7ORjeI8MSts0QW8mb9EOCRtkwgr1MBlsgum2yaedB2XkTd4RDRkJYUrPiifOdAme372nxY_Pn74vvuLziy_Lxdk5thVVEzbKSckko40yXFBWM-YqqaTiyjpXEQPO0CoH4gyrpWvKFWOKNrYmREhJCD8tPhx0h7npYWWz92g6PYy-N-NWR-P13z_BX-k2rnVeNue5E-AHgc5DCzqOjddrtifu57lrtbG6Ac2YUJqTWnKRWa_vbMd4M0OadO-Tha4zAXKYmsmSV6TivM7QV_9Ar-M85ugySpWKUEGrKqPYAWXHmNII7v4ESvSuF_rQC517ofe90JtMevnn8feU30V4OC7lr9DC-OD9H9lfOcrB3A</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Di Gennaro, Francesco</creator><creator>Belati, Alessandra</creator><creator>Tulone, Ottavia</creator><creator>Diella, Lucia</creator><creator>Fiore Bavaro, Davide</creator><creator>Bonica, Roberta</creator><creator>Genna, Vincenzo</creator><creator>Smith, Lee</creator><creator>Trott, Mike</creator><creator>Bruyere, Olivier</creator><creator>Mirarchi, Luigi</creator><creator>Cusumano, Claudia</creator><creator>Dominguez, Ligia Juliana</creator><creator>Saracino, Annalisa</creator><creator>Veronese, Nicola</creator><creator>Barbagallo, Mario</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><general>Springer Science and Business Media Deutschland GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>Q33</scope><scope>5PM</scope></search><sort><creationdate>20230801</creationdate><title>Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients</title><author>Di Gennaro, Francesco ; Belati, Alessandra ; Tulone, Ottavia ; Diella, Lucia ; Fiore Bavaro, Davide ; Bonica, Roberta ; Genna, Vincenzo ; Smith, Lee ; Trott, Mike ; Bruyere, Olivier ; Mirarchi, Luigi ; Cusumano, Claudia ; Dominguez, Ligia Juliana ; Saracino, Annalisa ; Veronese, Nicola ; Barbagallo, Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-a8f772721b8a3612922f5787838cff50aefa15173fa297fb4d2281bc900677003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ce-Systematic Reviews and Meta-analysis</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 : diagnosis</topic><topic>Emergency Medicine</topic><topic>Female</topic><topic>Human health sciences</topic><topic>Humans</topic><topic>Incidence</topic><topic>Internal Medicine</topic><topic>Long COVID</topic><topic>Male</topic><topic>management and prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Observational studies</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>Public health, health care sciences & services</topic><topic>RNA, Viral</topic><topic>Santé publique, services médicaux & soins de santé</topic><topic>SARS-CoV-2</topic><topic>Sciences de la santé humaine</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Di Gennaro, Francesco</creatorcontrib><creatorcontrib>Belati, Alessandra</creatorcontrib><creatorcontrib>Tulone, Ottavia</creatorcontrib><creatorcontrib>Diella, Lucia</creatorcontrib><creatorcontrib>Fiore Bavaro, Davide</creatorcontrib><creatorcontrib>Bonica, Roberta</creatorcontrib><creatorcontrib>Genna, Vincenzo</creatorcontrib><creatorcontrib>Smith, Lee</creatorcontrib><creatorcontrib>Trott, Mike</creatorcontrib><creatorcontrib>Bruyere, Olivier</creatorcontrib><creatorcontrib>Mirarchi, Luigi</creatorcontrib><creatorcontrib>Cusumano, Claudia</creatorcontrib><creatorcontrib>Dominguez, Ligia Juliana</creatorcontrib><creatorcontrib>Saracino, Annalisa</creatorcontrib><creatorcontrib>Veronese, Nicola</creatorcontrib><creatorcontrib>Barbagallo, Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal and emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Di Gennaro, Francesco</au><au>Belati, Alessandra</au><au>Tulone, Ottavia</au><au>Diella, Lucia</au><au>Fiore Bavaro, Davide</au><au>Bonica, Roberta</au><au>Genna, Vincenzo</au><au>Smith, Lee</au><au>Trott, Mike</au><au>Bruyere, Olivier</au><au>Mirarchi, Luigi</au><au>Cusumano, Claudia</au><au>Dominguez, Ligia Juliana</au><au>Saracino, Annalisa</au><au>Veronese, Nicola</au><au>Barbagallo, Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients</atitle><jtitle>Internal and emergency medicine</jtitle><stitle>Intern Emerg Med</stitle><addtitle>Intern Emerg Med</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>18</volume><issue>5</issue><spage>1573</spage><epage>1581</epage><pages>1573-1581</pages><issn>1828-0447</issn><eissn>1970-9366</eissn><abstract>The long-term consequences of the coronavirus disease 19 (COVID-19) are likely to be frequent but results hitherto are inconclusive. Therefore, we aimed to define the incidence of long-term COVID signs and symptoms as defined by the World Health Organization, using a systematic review and meta-analysis of observational studies. A systematic search in several databases was carried out up to 12 January 2022 for observational studies reporting the cumulative incidence of long COVID signs and symptoms divided according to body systems affected. Data are reported as incidence and 95% confidence intervals (CIs). Several sensitivity and meta-regression analyses were performed. Among 11,162 papers initially screened, 196 were included, consisting of 120,970 participants (mean age: 52.3 years; 48.8% females) who were followed-up for a median of six months. The incidence of any long COVID symptomatology was 56.9% (95% CI 52.2–61.6). General long COVID signs and symptoms were the most frequent (incidence of 31%) and digestive issues the least frequent (7.7%). The presence of any neurological, general and cardiovascular long COVID symptomatology was most frequent in females. Higher mean age was associated with higher incidence of psychiatric, respiratory, general, digestive and skin conditions. The incidence of long COVID symptomatology was different according to continent and follow-up length. Long COVID is a common condition in patients who have been infected with SARS-CoV-2, regardless of the severity of the acute illness, indicating the need for more cohort studies on this topic.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36449260</pmid><doi>10.1007/s11739-022-03164-w</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1828-0447 |
| ispartof | Internal and emergency medicine, 2023-08, Vol.18 (5), p.1573-1581 |
| issn | 1828-0447 1970-9366 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9709360 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Ce-Systematic Reviews and Meta-analysis Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology COVID-19 : diagnosis Emergency Medicine Female Human health sciences Humans Incidence Internal Medicine Long COVID Male management and prognosis Medicine Medicine & Public Health Meta-analysis Middle Aged Observational studies Post-Acute COVID-19 Syndrome Public health, health care sciences & services RNA, Viral Santé publique, services médicaux & soins de santé SARS-CoV-2 Sciences de la santé humaine Severe acute respiratory syndrome coronavirus 2 Systematic review |
| title | Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T00%3A05%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20of%20long%20COVID-19%20in%20people%20with%20previous%20SARS-Cov2%20infection:%20a%20systematic%20review%20and%20meta-analysis%20of%20120,970%20patients&rft.jtitle=Internal%20and%20emergency%20medicine&rft.au=Di%20Gennaro,%20Francesco&rft.date=2023-08-01&rft.volume=18&rft.issue=5&rft.spage=1573&rft.epage=1581&rft.pages=1573-1581&rft.issn=1828-0447&rft.eissn=1970-9366&rft_id=info:doi/10.1007/s11739-022-03164-w&rft_dat=%3Cproquest_pubme%3E2848016155%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2848016155&rft_id=info:pmid/36449260&rfr_iscdi=true |